NEW YORK, Dec. 5, 2016 /PRNewswire/ -- Rosen Law Firm,
a global investor rights law firm, reminds purchasers of common
stock of Mylan Inc., predecessor of Mylan N.V., and/or Mylan N.V.
ordinary shares (NASDAQ: MYL) from February 28, 2013 through October 7, 2016, both dates inclusive (the "Class
Period") of the important December 12,
2016 lead plaintiff deadline in the class action filed by
the firm. The lawsuit seeks to recover damages for Mylan investors
under the federal securities laws.
To join the Mylan class action, go to
http://www.rosenlegal.com/cases-967.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or
email pkim@rosenlegal.com or kchan@rosenlegal.com for information
on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A
CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU
RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO
NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, throughout the Class Period defendants
made false and/or misleading statements and/or failed to disclose
that: (1) Mylan N.V. and Mylan Inc. incorrectly classified EpiPen
as a generic under the Medicaid Drug Rebate Program, which was
financially consequential for federal and state governments as it
reduced the amount of quarterly rebates Mylan N.V. and Mylan Inc.
owed for EpiPen; (2) between 2011 through 2015, Mylan N.V. and
Mylan Inc. paid a lower rebate of 13% when it should have been
paying a higher rebate of 23.1% or more; (3) the incorrect
classification appears to have cost the federal government more
than $100 million in the last five
years alone; (4) in turn, Mylan N.V. and Mylan Inc. lacked
effective internal controls over financial reporting; and (5) as a
result, Mylan N.V. and Mylan Inc.'s public statements were
materially false and misleading at all relevant times. The lawsuit
claims that investors suffered damages when these details entered
the market.
A class action lawsuit has already been filed. If you wish to
serve as lead plaintiff, you must move the Court no later than
December 12, 2016. If you wish to
join the litigation, go to http://www.rosenlegal.com/cases-967.html
or to discuss your rights or interests regarding this class action,
please contact Phillip Kim or
Kevin Chan of Rosen Law Firm toll
free at 866-767-3653 or via email at pkim@rosenlegal.com or
kchan@rosenlegal.com. Attorney Advertising. Prior results do not
guarantee a similar outcome.
Follow us for updates on LinkedIn:
https://www.linkedin.com/company/the-rosen-law-firm or on Twitter:
https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe,
concentrating its practice in securities class actions and
shareholder derivative litigation.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
Kevin Chan, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
kchan@rosenlegal.com
www.rosenlegal.com
Logo - http://photos.prnewswire.com/prnh/20160907/405060LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/rosen-law-firm-reminds-mylan-nv-investors-of-important-dec-12-deadline-in-class-action-filed-by-firm---myl-300373104.html
SOURCE Rosen Law Firm, P.A.